301033 迈普医学
已收盘 12-16 15:00:00
资讯
新帖
简况
迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%
证券之星 · 12-15 18:12
迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%
12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）
新浪证券 · 12-12
12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）
迈普医学最新公告：股东国寿成达减持1.00%股份
证券之星 · 12-12
迈普医学最新公告：股东国寿成达减持1.00%股份
迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份
智通财经 · 12-12
迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份
12月5日迈普医学现683.87万元大宗交易
证券之星 · 12-05
12月5日迈普医学现683.87万元大宗交易
迈普医学实际控制人袁玉宇解除质押221万股股份
中金财经 · 12-01
迈普医学实际控制人袁玉宇解除质押221万股股份
迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%
证券之星 · 11-21
迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%
证券之星 · 11-19
迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%
迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，11月13日股价下跌0.22%
证券之星 · 11-13
迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，11月13日股价下跌0.22%
迈普医学最新公告：发行股份及支付现金购买资产并募集配套资金的申请文件获得深交所受理
证券之星 · 11-13
迈普医学最新公告：发行股份及支付现金购买资产并募集配套资金的申请文件获得深交所受理
迈普医学最新公告：股东国寿成达拟减持不超1.00%股份
证券之星 · 11-10
迈普医学最新公告：股东国寿成达拟减持不超1.00%股份
11月4日迈普医学跌5.83%，大成价值增长混合A基金重仓该股
证券之星 · 11-04
11月4日迈普医学跌5.83%，大成价值增长混合A基金重仓该股
迈普医学股东会通过重大资产重组方案
中金财经 · 11-03
迈普医学股东会通过重大资产重组方案
10月28日迈普医学发布公告，股东减持66.51万股
证券之星 · 10-28
10月28日迈普医学发布公告，股东减持66.51万股
股市必读：迈普医学(301033)股东户数0.6万户，较上期减少2.36%
证券之星 · 10-27
股市必读：迈普医学(301033)股东户数0.6万户，较上期减少2.36%
迈普医学（301033）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 10-25
迈普医学（301033）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
迈普医学(301033)9月30日股东户数0.6万户，较上期减少2.36%
证券之星 · 10-24
迈普医学(301033)9月30日股东户数0.6万户，较上期减少2.36%
迈普医学(301033.SZ)发布前三季度业绩，归母净利润7585.4万元，增长43.65%
智通财经 · 10-23
迈普医学(301033.SZ)发布前三季度业绩，归母净利润7585.4万元，增长43.65%
迈普医学最新公告：与关联方签订产品销售代理合作协议
证券之星 · 10-23
迈普医学最新公告：与关联方签订产品销售代理合作协议
迈普医学（301033）披露重组报告书暨一般风险提示性公告，10月17日股价下跌3.83%
证券之星 · 10-17
迈普医学（301033）披露重组报告书暨一般风险提示性公告，10月17日股价下跌3.83%
暂无数据
公司概况
公司名称：
广州迈普再生医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-07-26
主营业务：
广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素及硬脑膜医用胶。
发行价格：
15.14
{"stockData":{"symbol":"301033","market":"SZ","secType":"STK","nameCN":"迈普医学","latestPrice":66.53,"timestamp":1765868595000,"preClose":67.33,"halted":0,"volume":509807,"delay":0,"changeRate":-0.0119,"floatShares":56469100,"shares":67049600,"eps":1.5199,"marketStatus":"已收盘","change":-0.8,"latestTime":"12-16 15:00:00","open":67.32,"high":67.58,"low":66.01,"amount":34017300,"amplitude":0.0233,"askPrice":66.8,"askSize":36,"bidPrice":66.53,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.5199,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":67.33,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":74.06,"lowLimit":60.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":67049620,"isCdr":false,"pbRate":6.01,"roa":"--","peRate":43.772617,"roe":"10.43%","epsLYR":1.2,"committee":-0.394286,"marketValue":4461000000,"turnoverRate":0.009,"status":1,"floatMarketCap":3757000000},"requestUrl":"/m/hq/s/301033/tweets","defaultTab":"tweets","newsList":[{"id":"2591610814","title":"迈普医学（301033）披露公司首发前股东减持股份计划实施完成公告，12月15日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591610814","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591610814?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:12","pubTimestamp":1765793537,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，迈普医学报收于67.33元，较前一交易日上涨2.28%，最新总市值为45.14亿元。该股当日开盘64.9元，最高68.39元，最低64.9元，成交额达6186.58万元，换手率为1.63%。近日，迈普医学发布关于公司首发前股东减持股份计划实施完成的公告。本次减持计划已实施完成，符合相关法律法规及承诺，未导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500024143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2590745509","title":"12月12日增减持汇总：迈普医学等7家公司减持 无A股增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2590745509","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590745509?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:02","pubTimestamp":1765544520,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，12月12日，盘后迈普医学、盈新发展（维权）、西陇科学（维权）、亚翔集成、梦百合、永鼎股份、金辰股份等7家A股上市公司披露减持情况。当日暂无上市公司披露增持情况。\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-12/doc-inhaqapf5042580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301033","399300","BK0251","159982"],"gpt_icon":0},{"id":"2590023506","title":"迈普医学最新公告：股东国寿成达减持1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590023506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590023506?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:50","pubTimestamp":1765543827,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，股东国寿成达通过集中竞价交易方式减持公司股份67.05万股，占公司总股本的1.0000%，减持期间为2025年12月2日至2025年12月11日，减持价格区间为62.99元/股至65.60元/股，减持股份来源为首次公开发行前取得的股份。本次减持后，国寿成达持有公司股份比例由1.8969%降至0.8969%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200037897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2590067905","title":"迈普医学(301033.SZ)股东深圳凯盈、风炎基金拟减持不超1.22%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590067905","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590067905?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:49","pubTimestamp":1765543796,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)公告，公司收到公司股东深圳凯盈、风炎基金分别出具的《关于计划减持股份的告知函》，深圳凯盈拟减持不超过15万股，即不超过公司总股本的0.2237%;风炎基金拟减持不超过66.81万股，占公司当前股本的0.9964%(占剔除公司回购专用账户后总股本的1.0000%)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2589893687","title":"12月5日迈普医学现683.87万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2589893687","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589893687?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:42","pubTimestamp":1764927766,"startTime":"0","endTime":"0","summary":"证券之星消息，12月5日迈普医学发生大宗交易，交易数据如下：大宗交易成交价格62.17元，相对当日收盘价折价1.51%，成交11万股，成交金额683.87万元，买方营业部为中信证券股份有限公司北京呼家楼证券营业部，卖方营业部为国信证券股份有限公司深圳泰然九路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1100.0手，折价成交1笔。截至2025年12月5日收盘，迈普医学报收于63.12元，上涨0.8%，换手率0.63%，成交量3542.0手，成交额2221.62万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2588239527","title":"迈普医学实际控制人袁玉宇解除质押221万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2588239527","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588239527?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:22","pubTimestamp":1764580938,"startTime":"0","endTime":"0","summary":"中访网数据 广州迈普再生医学科技股份有限公司于近日发布公告，公司实际控制人、控股股东袁玉宇先生将其持有的部分公司股份办理了解除质押手续。本次解除质押股份数量为221万股，占其所持公司股份比例的19.94%，占公司总股本的3.30%。其中，袁玉宇先生累计质押股份数量为483万股，占其个人所持股份的43.59%，占公司总股本的7.20%；徐弢先生所持股份目前无质押情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251201/31835690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2585141439","title":"迈普医学（301033）披露公司章程（2025年11月），11月21日股价下跌3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141439","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141439?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:54","pubTimestamp":1763736864,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，迈普医学报收于63.0元，较前一交易日下跌3.02%，最新总市值为42.24亿元。该股当日开盘64.7元，最高65.33元，最低62.78元，成交额达3413.56万元，换手率为0.95%。近日，迈普医学发布公告称，公司对《广州迈普再生医学科技股份有限公司章程》进行了修订。章程明确公司注册资本为67,049,620.00元，股份总数为普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100041161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2584947117","title":"迈普医学（301033）披露公司实际控制人、控股股东部分股份解除质押的公告，11月19日股价下跌1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947117","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947117?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:35","pubTimestamp":1763562923,"startTime":"0","endTime":"0","summary":"迈普医学于近日发布公告，公司实际控制人、控股股东袁玉宇先生将其所持有的1,040,000股公司股份办理了解除质押手续，占其所持股份比例9.39%，占公司总股本比例1.55%，质权人为深圳市高新投小额贷款有限公司。本次解除质押后，袁玉宇累计质押股份为7,040,000股，占其所持股份比例63.53%。截至公告日，公司实际控制人及其一致行动人所持股份无冻结或拍卖情况，质押股份无平仓风险，不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2583559985","title":"迈普医学（301033）披露公司实际控制人、控股股东部分股份质押的公告，11月13日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583559985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583559985?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:25","pubTimestamp":1763043923,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，迈普医学报收于68.8元，较前一交易日下跌0.22%，最新总市值为46.13亿元。当日，公司发布公告称，实际控制人、控股股东袁玉宇先生将其持有的2,600,000股公司股份质押给云南国际信托有限公司，用于个人融资。本次质押占其所持股份比例23.46%，占公司总股本比例3.88%。公告指出，质押股份不涉及重大资产重组业绩补偿义务，本次质押不影响公司控制权稳定，无平仓风险，不损害上市公司利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300042320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2583680645","title":"迈普医学最新公告：发行股份及支付现金购买资产并募集配套资金的申请文件获得深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2583680645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583680645?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:49","pubTimestamp":1763027373,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，公司于2025年11月12日收到深交所出具的《关于受理广州迈普再生医学科技股份有限公司发行股份购买资产并募集配套资金申请文件的通知》，深交所对申请文件进行了核对，认为齐备，符合法定形式，决定予以受理并依法进行审核。本次交易尚需履行多项审批程序方可实施，包括深交所审核通过、中国证监会同意注册等。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300030978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2582875850","title":"迈普医学最新公告：股东国寿成达拟减持不超1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582875850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582875850?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:10","pubTimestamp":1762776620,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，公司首发前股东国寿成达（上海）健康产业股权投资中心（有限合伙）计划通过集中竞价交易方式减持不超过67.05万股，占公司总股本的1.0000%。减持原因为自身经营需要，减持期间为本公告披露之日起15个交易日后的3个月内。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000030663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2580885247","title":"11月4日迈普医学跌5.83%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2580885247","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580885247?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:33","pubTimestamp":1762245208,"startTime":"0","endTime":"0","summary":"证券之星消息，11月4日迈普医学跌5.83%，收盘报67.68元，换手率1.84%，成交量1.04万手，成交额7123.49万元。重仓迈普医学的前十大公募基金请见下表：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为91.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共18家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。该公募基金现任基金经理为杨挺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400025559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2580299620","title":"迈普医学股东会通过重大资产重组方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2580299620","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580299620?lang=zh_cn&edition=full","pubTime":"2025-11-03 18:41","pubTimestamp":1762166514,"startTime":"0","endTime":"0","summary":"中访网数据 广州迈普再生医学科技股份有限公司于2025年11月3日召开2025年第三次临时股东会，会议审议并高票通过了公司发行股份及支付现金购买资产并募集配套资金暨关联交易相关的全部22项议案。根据表决结果，所有议案均获得了出席会议股东所持有效表决权股份总数三分之二以上的同意，支持率普遍超过99%，展现了股东对此次资本运作的高度认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251103/31763170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2578524209","title":"10月28日迈普医学发布公告，股东减持66.51万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2578524209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578524209?lang=zh_cn&edition=full","pubTime":"2025-10-28 21:01","pubTimestamp":1761656519,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日迈普医学发布公告《迈普医学:关于公司股东减持股份计划实施完成的公告》，其股东唐莹于2025年7月30日至2025年10月27日间合计减持66.51万股，占公司目前总股本的0.992%，变动期间该股股价下跌1.47%，截止10月27日收盘报73.5元。股东增减持详情见下表：根据迈普医学2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800040636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2578657070","title":"股市必读：迈普医学(301033)股东户数0.6万户，较上期减少2.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578657070","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578657070?lang=zh_cn&edition=full","pubTime":"2025-10-27 05:10","pubTimestamp":1761513026,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，迈普医学报收于72.26元，上涨3.23%，换手率1.8%，成交量1.01万手，成交额7328.71万元。来自股本股东变化：截至2025年9月30日，公司股东户数环比下降2.36%，户均持股数量上升至1.1万股。股本股东变化股东户数变动截至2025年9月30日，迈普医学股东户数为6043.0户，较6月30日减少146.0户，减幅2.36%；户均持股数量升至1.1万股，户均持股市值为79.52万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2578257625","title":"迈普医学（301033）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578257625","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578257625?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:11","pubTimestamp":1761343871,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期迈普医学发布2025年三季报。截至本报告期末，公司营业总收入2.49亿元，同比上升30.53%，归母净利润7585.4万元，同比上升43.65%。按单季度数据看，第三季度营业总收入9145.06万元，同比上升32.74%，第三季度归母净利润2855.49万元，同比上升39.89%。本报告期迈普医学盈利能力上升，毛利率同比增幅3.38%，净利率同比增幅10.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033"],"gpt_icon":0},{"id":"2577599506","title":"迈普医学(301033)9月30日股东户数0.6万户，较上期减少2.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577599506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577599506?lang=zh_cn&edition=full","pubTime":"2025-10-24 17:18","pubTimestamp":1761297493,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迈普医学披露，截至2025年9月30日公司股东户数为6043.0户，较6月30日减少146.0户，减幅为2.36%。在医疗器械行业个股中，迈普医学股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，迈普医学区间涨幅为20.11%，在此期间股东户数减少146.0户，减幅为2.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400030781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2577301157","title":"迈普医学(301033.SZ)发布前三季度业绩，归母净利润7585.4万元，增长43.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577301157","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577301157?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:14","pubTimestamp":1761221692,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)发布2025年三季度报告，该公司前三季度营业收入为2.49亿元，同比增长30.53%。归属于上市公司股东的净利润为7585.4万元，同比增长43.65%。归属于上市公司股东的扣除非经常性损益的净利润为7279.19万元，同比增长57.94%。基本每股收益为1.15元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301033"],"gpt_icon":0},{"id":"2577303877","title":"迈普医学最新公告：与关联方签订产品销售代理合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2577303877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577303877?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:50","pubTimestamp":1761216653,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，公司拟与江西司托迈医疗科技有限公司和江西远赛医疗科技有限公司分别签订协议，司托迈委托公司独家代理销售持续葡萄糖监测系统产品，代理期限自2025年11月1日至2026年12月31日，预估采购金额为2,150万元；远赛医疗委托公司独家代理销售超声软组织手术设备及手术刀头产品，代理期限自协议生效日至2026年12月31日，预估采购金额为350万元。上述交易构成关联交易，不构成重大资产重组。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300030943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2576161080","title":"迈普医学（301033）披露重组报告书暨一般风险提示性公告，10月17日股价下跌3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576161080","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576161080?lang=zh_cn&edition=full","pubTime":"2025-10-17 17:12","pubTimestamp":1760692342,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，迈普医学报收于68.3元，较前一交易日下跌3.83%，最新总市值为45.5亿元。具体内容详见同日发布的《广州迈普再生医学科技股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）》等相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700027072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765916204073,"stockEarnings":[{"period":"1week","weight":0.0368},{"period":"1month","weight":-0.0548},{"period":"3month","weight":-0.1237},{"period":"6month","weight":0.1979},{"period":"1year","weight":0.4625},{"period":"ytd","weight":0.5971}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州迈普再生医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6043人(较上一季度减少2.36%)","perCapita":"9344股","listingDate":"2021-07-26","address":"广东省广州市黄埔区崖鹰石路3号","registeredCapital":"6704万元","survey":" 广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素及硬脑膜医用胶。","listedPrice":15.14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈普医学,301033,迈普医学股票,迈普医学股票老虎,迈普医学股票老虎国际,迈普医学行情,迈普医学股票行情,迈普医学股价,迈普医学股市,迈普医学股票价格,迈普医学股票交易,迈普医学股票购买,迈普医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}